US5847101AExpiredUtility

Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide

81
Assignee: UNIV OSAKA RES FOUNDPriority: Jun 25, 1990Filed: Feb 6, 1995Granted: Dec 8, 1998
Est. expiryJun 25, 2010(expired)· nominal 20-yr term from priority
Inventors:Hiroto OkayamaIsao FukeChisato MoriAkihisa TakamizawaIwao Yoshida
Y10S930/223C12N 2770/24222C07K 14/005A61K 39/00
81
PatentIndex Score
55
Cited by
32
References
11
Claims

Abstract

Disclosed is an isolated non-A, non-B hepatitis virus genomic cDNA covering the entire region of the virus gene nucleotide sequence from the 1st to 9416th nucleotides shown in FIG. 2(1) through FIG. 2(16) hereof, wherein the coding region is from the 333rd to 9362nd nucleotides, and the 5'- and 3'-noncoding sequences contain 332 nucleotides and 54 nucleotides, respectively. Part of the cDNA and an antigen polypeptide as an expression product thereof are useful as a diagnostic reagent for non-A, non-B hepatitis. The antigen polypeptide is also useful as an active ingredient for a non-A, non-B hepatitis virus vaccine.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. An isolated deoxyribonucleic acid comprising at least one nucleotide sequence the same as or complementary to a non-A, non-B hepatitis virus nucleotide sequence selected from the group consisting of SEQ ID NO. 5, SEQ ID NO. 7, SEC ID NO. 9, SEQ ID NO. 11, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEC ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 33, SEQ ID NO. 37 SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49 and SEQ ID NO. 1.   
     
     
       2. A replicable recombinant DNA molecule comprising a replicable expression plasmid vector and a deoxyribonucleic acid comprising at least one nucleotide sequence the same as or complementary to a non-A, non-B hepatitis virus nucleotide sequence selected from the group consisting of SEQ ID NO. 5, SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 33, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47 and SEQ ID NO. 49.   
     
     
       3. A substantially pure RNA synthesized using as a template a deoxyribonucleic acid comprising at least one nucleotide sequence selected from the group consisting of SEQ ID NO. 5, SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 11, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 33, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49 and SEQ ID NO. 1.   
     
     
       4. Escherichia coli strain BK108 carrying a non-A, non-B hepatitis virus genomic cDNA, deposited at Fermentation Research Institute, Japan under the accession number FERM BP-2971. 
     
     
       5. Escherichia coli strain BK129 carrying a non-A, non-B hepatitis virus genomic cDNA, deposited at Fermentation Research Institute, Japan under the accession number FERM BP-2972. 
     
     
       6. Escherichia coli strain BK138 carrying a non-A, non-B hepatitis virus genomic cDNA, deposited at Fermentation Research Institute, Japan under the accession number FERM BP-2973. 
     
     
       7. Escherichia coli strain BK153 carrying a non-A, non-B hepatitis virus genomic cDNA, deposited at Fermentation Research Institute, Japan under the accession number FERM BP-2974. 
     
     
       8. Escherichia coli strain BK166 carrying a non-A, non-B hepatitis virus genomic cDNA, deposited at Fermentation Research Institute, Japan under the accession number FERM BP-2975. 
     
     
       9. Escherichia coli strain BK172 carrying a non-A, non-B hepatitis virus genomic cDNA, deposited at Fermentation Research Institute, Japan under the accession number FERM BP-2976. 
     
     
       10. A diagnostic reagent for the detection of non-A, non-B hepatitis by hybridization or polymerase chain reaction, comprising an effective amount, for the hybridization or polymerase chain reaction, of an isolated deoxyribonucleic acid comprising at least one nucleotide sequence the same as or complementary to a non-A, non-B hepatitis virus nucleotide sequence selected from the group consisting of SEQ ID NO. 5, SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 11, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 33, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49 and SEQ ID NO. 1.   
     
     
       11. A replicable recombinant virus gene molecule comprising a replicable expression animal virus gene vector and a deoxyribonucleic acid comprising at least one nucleotide sequence the same as or complementary to a non-A, non-B hepatitis virus nucleotide sequence selected from the group consisting of SEQ ID NO. 5, SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 33, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, and SEQ ID NO. 49.

Join the waitlist — get patent alerts

Track US5847101A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.